Damage to brain functioning could be due not only to organic (physical) injury (a severe blow to the head, stroke, chemical and toxic exposures, organic brain disease, substance use, etc.) and also to non-organic means such as severe deprivation, abuse, neglect, and severe psychological trauma. Symptoms
Many of the symptoms of Organic Mental Disorder depend on the cause of the disorder, but are similar and include physical or behavioral elements. Dementia and delirium are the cause of the confusion, orientation, cognition or alertness impairment. Therefore, these symptoms require more attention because hallucinations, delusions, amnesia, and personality changes are the result. These effects of the dementia and delirium are not joined with the changes of sensory or perception abilities. Memory impairment, judgment, logical function and agitation are also some extremely common symptoms. The more common symptoms of OBS are confusion; impairment of memory, judgment, and intellectual function;  and agitation. Often these symptoms are attributed to psychiatric illness, which causes a difficulty in diagnosis. Associated conditions
Disorders that are related to injury or damage to the brain and contribute to OBS include, but are not limited to:

Alcoholism
Alzheimers disease
Attention deficit/hyperactivity disorder
Autism
Concussion
Encephalitis
Epilepsy
Fetal alcohol syndrome
Hypoxia
Parkinsons disease
Intoxication/overdose caused by substance use disorders including alcohol use disorder
Non-medical use of sedative hypnotics
Intracranial hemorrhage/trauma
Korsakoff syndrome
Mastocytosis
Meningitis
Psychoorganic syndrome
Stroke/transient ischemic attack (TIA)
Withdrawal from drugs, especially sedative hypnotics, e.g. alcohol or benzodiazepinesOther conditions that may be related to organic brain syndrome include: clinical depression, neuroses, and psychoses, which may occur simultaneously with the OBS.
The carbon 10 functional group change causes docetaxel to be more water-soluble than paclitaxel. Formulations and compositions
Docetaxel is a white powder and is the active ingredient available in 20 mg and 80 mg Taxotere single-dose vials of concentrated anhydrous docetaxel in polysorbate 80. The solution is a clear brown-yellow containing 40 mg docetaxel and 1040 mg polysorbate 80 per mL. 20 mg Taxotere is distributed in a blister carton containing one single-dose vial of Taxotere (docetaxel) preparation in 0.5 mL sterile pyrogen-free anhydrous polysorbate 80, and a single dose Taxotere solvent vial containing 1.5 mL 13% ethanol in saline to be combined and diluted in a 250 mL infusion bag containing 0.9% sodium chloride or 5% glucose for administration. 80 mg Taxotere is supplied identically but with 2.0 mL polysorbate 80 and 6.0 mL 13% ethanol in saline. The docetaxel and solvent vials are combined to give a solution of 10 mg/mL and the required dose is drawn from this solution. Vials have an overfill to compensate for liquid loss during preparation, foaming, adhesion to vial walls and the dead volume. 20 mg vials may be stored for 24 months below 25 °C away from light and 80 mg vials for 26 months in the same conditions.Recently Sanofi has got approval for one-vial formulation. With this one-vial formulation, the preparation of the infusion solution is simplified by eliminating the first dilution step. The two-vial and one-vial formulations contain the same drug substance, docetaxel trihydrate, and the same excipients (ethanol, polysorbate 80 and citric acid).